1. Home
  2. Labeler Index
  3. Remedyrepack Inc.
  4. 70518-1746
  5. Product Images: Spironolactone

Product Images Spironolactone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Spironolactone NDC 70518-1746 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

Spironolactone is a prescription medication available in a quantity of 30 HD2 tablets. It is a medication that requires a prescription or RX. The product is associated with NDC #: 70518-1746-00, and its lot number and expiry date are not available. The medication is manufactured by Accerd, Durham, NC 27703. It should be stored between 20-26°C (63-77°F), and excursions are permitted up to 15-30°C (59-86°F) as per USP. The package includes directions for use. The medication is repackaged by RemedyRepack Inc., Indiana, PA 15701. Care must be taken to keep this and all medication out of the reach of children.*

Spironolactone 100mg 70518 1746 01

Spironolactone 100mg 70518 1746 01

Spironolactone is a prescription drug available in a bottle of 30 tablets. The lot number and expiration date are missing. The National Drug Code (NDC) is 70518-1746-01, which can be traced back to the manufacturer, Accerd, in Durham, NC. The drug should be kept out of the reach of children and stored between 20-26°C (63-77°F) with excursions permitted between 15-30°C (59-86°F). The package insert should be consulted for usage instructions. The drug has been repackaged by RemedyRepack Inc. in Indiana, PA.*

Figure 1. Survival by Treatment Group in The Randomized Spironolactone Evaluation Study - spironolactone figure 1

Figure 1. Survival by Treatment Group in The Randomized Spironolactone Evaluation Study - spironolactone figure 1

Figure 2. Hazard Ratios of All-Cause Mortality by Subgroup in The Randomized Spironolactone Evaluation Study - spironolactone figure 2

Figure 2. Hazard Ratios of All-Cause Mortality by Subgroup in The Randomized Spironolactone Evaluation Study - spironolactone figure 2

This text appears to be a graph or chart with the title "Subgroup" and some values or categories labeled along the X and Y axes. The words "Spironolactone better" and "Placebo better" are included, but it is unclear what they refer to without additional context. Therefore, it is not possible to generate a useful description with this information alone.*

Chemical Structure - spironolactone structure image

Chemical Structure - spironolactone structure image

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.